iifl-logo

ICICI Pru Nifty Pharma Index Fund Dir G

ICICI Pru Nifty Pharma Index Fund Dir G

Fund Name

ICICI Prudential Mutual Fund

Scheme Name

ICICI Pru Nifty Pharma Index Fund Dir G

AMC

ICICI Prudential Mutual Fund

Type

:  Open

Category

Equity - Index

Launch Date

25-Nov-2022

Fund Manager

Nishit Patel

Net Assets (Rs. cr)

156.88

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Karvy Customer: For activating your account click here.

ICICI Pru Nifty Pharma Index Fund Dir G - Nav Details

Nav Date

:  18-Sep-2026

NAV [Rs.]

:  20.6841

Buy/Resale Price [Rs.]

0

Sell/Repurchase Price [Rs.]

0

Entry Load %

Nil

Exit Load %

Nil

ICICI Pru Nifty Pharma Index Fund Dir G- NAV Chart

ICICI Pru Nifty Pharma Index Fund Dir G- Performance(%)

Returns above 1 yr. are annualized

1W
1M
3M
6M
1Y
3Y
5Y
Since INC
Scheme Returns
0.66
1.29
10.14
18.15
18.45
19.9
-
21.29
Category Avg
-0.29
-2.77
-0.89
6.08
-1.27
10.53
8.83
6.44
Category Best
1.82
1.87
11.5
29.7
31.59
30.87
17.84
27.85
Category Worst
-3.84
-7.38
-8.66
-8.74
-24.32
-3.49
4.44
-20.57

ICICI Pru Nifty Pharma Index Fund Dir G- Latest Dividends

No Records Found

ICICI Pru Nifty Pharma Index Fund Dir G- Investment Details

Min. Investment(Rs.)

1000

Increm.Investment(Rs.)

1000

In & Out

In

InName Of The CompanyNo Of Shares
--

Out

InName Of The CompanyNo Of Shares
--

Fund Holdings

Asset Type
Instrument Name
Industry
Net Assets(%)
No of Shares
Mkt Value(Cr.)
Equity & Equity related Investments
EquitySun Pharma.Inds.Pharmaceuticals & Biotechnology20.7616410632.57
EquityDivi's Lab.Pharmaceuticals & Biotechnology11.881968818.63
EquityCiplaPharmaceuticals & Biotechnology7.838720012.28
EquityLaurus LabsPharmaceuticals & Biotechnology7.356029211.54
EquityTorrent Pharma.Pharmaceuticals & Biotechnology7.332272411.51
EquityDr Reddy's LabsPharmaceuticals & Biotechnology6.959447110.90
EquityLupinPharmaceuticals & Biotechnology5.24376318.23
EquityAurobindo PharmaPharmaceuticals & Biotechnology4.69428917.36
EquityGlenmark Pharma.Pharmaceuticals & Biotechnology3.68233255.78
EquityAlkem LabPharmaceuticals & Biotechnology3.0790564.82
EquityBioconPharmaceuticals & Biotechnology2.901105704.55
EquityZydus Lifesci.Pharmaceuticals & Biotechnology2.86387684.50
EquityIpca Labs.Pharmaceuticals & Biotechnology2.70215184.24
EquityMankind PharmaPharmaceuticals & Biotechnology2.70175344.24
EquityGland PharmaPharmaceuticals & Biotechnology2.27123413.56
EquitySai LifePharmaceuticals & Biotechnology1.98213743.12
EquityWockhardtPharmaceuticals & Biotechnology1.53127882.40
EquityAjanta PharmaPharmaceuticals & Biotechnology1.4965162.34
EquityPiramal PharmaPharmaceuticals & Biotechnology1.31963912.06
EquityAbbott IndiaPharmaceuticals & Biotechnology1.307952.05

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Karvy Customer: For activating your account click here.

MY WEALTH AT RETIREMENT

Calculate the worth of your wealth at retirement

Key information

Fund House:
ICICI Prudential Mutual Fund
Incorporation Date:
22-Jun-1993
Total Assets Managed (Cr.):
11,76,217.65
Trustee/s:
Mr. Lakshman Kumar Mylava, ICICI Prudential Trust Lt
Chairman:
NA
CEO / MD:
Mr. Nimesh Shah
CIO:
NA
President:
NA
Director/s:
Mr. Vijay Thacker, Mr. Nimesh Shah, Ms. Vibha Paul Rishi, Ms.Anubhuti Sanghai
Compliance Officer/s:
NA
Investor Service Officer/s:
Rajen Kotak
Fund Manager/s:
Nishit Patel
Auditors:
S.R.Batliboi & Co. LLP

OTHER INFORMATION

Registered Office:
One BKC, A-Wing, 13th Floor, Bandra Kurla Complex, Mumbai 400051
Contact Nos:
022 26525000
Fax:
022 26528100
Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2026, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099

ISO certification icon
We are ISO/IEC 27001:2022 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.